StonvexLoading…
StonvexStonvexStonvexCore line items from SDGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $58.59M | $255.87M | $168.63M | $114.31M |
Operating Income | $-48.79M | $-166.90M | $-149.74M | $-103.79M |
Net Income | $-60.03M | $-103.27M | $-135.78M | $-102.98M |
EPS (Diluted) | $-0.81 | $-1.41 | $-1.85 | $-1.41 |
Total Assets | $634.19M | $726.16M | $653.66M | $688.24M |
Total Liabilities | $320.64M | $362.11M | $332.31M | $345.37M |
Cash & Equivalents | $260.25M | $230.52M | $172.12M | $219.90M |
Free Cash Flow OCF − CapEx | $-17.34M | $12.46M | $28.59M | $90.95M |
Shares Outstanding | 73.99M | 73.44M | 73.37M | 73.24M |